About
Our Expertise
Strategic scientific communications for global pharmaceutical teams
Omni Medical offers medical writing services and impactful deliverables tailored specifically for pharmaceutical medical affairs and global medical communications teams. From peer-reviewed manuscripts and clinical study overviews to complex regulatory documents, our work is developed to meet the highest standards of rigorous editorial, peer-review, and Medical-Legal-Regulatory (MLR) scrutiny.
Every deliverable is anchored in meticulous, evidence-based sourcing. We ensure absolute precision in author attribution, strict alignment with current clinical guidelines, and flawless citation standards that fully comply with GPP 2022 and ISMPP ethical frameworks. We do not compromise on the details that dictate whether a manuscript survives peer review or a critical submission navigates a complex regulatory audit.
- Core Specialization
- Medical Affairs & Strategic Scientific Communications
- Deliverables
- Publication Strategy, Peer-Reviewed Manuscripts, Drug Monographs, and Regulatory Documents
- Compliance Standards
- GPP 2022, ICMJE, & ISMPP
Why Work With Us
Areas of Expertise
Deliverables across the development & commercialization lifecycle
From first-in-human protocols to post-launch field medical materials — writing calibrated to the audience, the regulatory standard, and the scientific record.
Medical Communications & Scientific Publications
Scientific dissemination of clinical evidence
Focused on the strategic planning, development, and transparent dissemination of clinical and scientific evidence to healthcare professionals and key scientific stakeholders.
Scientific Communication Platforms (SCPs)
Foundational strategic documents establishing the core scientific narrative, disease-state lexicon, evidence pillars, key messages, and molecular differentiation strategy.
Strategic Publication Plans
Multi-year publication roadmaps defining the sequence and timing of abstracts, posters, oral presentations, and peer-reviewed manuscripts across major scientific congresses and target journals.
Primary, Secondary & Subgroup Manuscripts
Peer-reviewed journal articles reporting primary efficacy endpoints, secondary outcomes, exploratory analyses, and post hoc subgroup analyses.
Congress Deliverables
Scientific abstracts, posters, oral presentation slide decks, encore presentations, and other congress-related scientific communications for major international meetings (e.g., ASCO, AHA, EADV, ADA, EASD).
Review Articles & Meta-Analyses
Comprehensive literature reviews, systematic reviews, and meta-analyses synthesizing the current evidence base and therapeutic landscape.
Plain Language Summaries (PLS/PLSP)
Non-technical summaries of peer-reviewed publications designed to improve accessibility for patients, caregivers, and non-specialist healthcare professionals. Includes Plain Language Summaries of Product Characteristics (PLSP) for EMA-compliant European submissions.
Publication Support Documents
Publication gap analyses, evidence and narrative gap assessments, publication steering committee materials, journal submission packages, authorship documentation, and publication metrics reports.
Publication Ethics & GPP Compliance
Advisory services supporting Good Publication Practice (GPP4) and ICMJE guideline adherence, including authorship compliance reviews, ethical publication planning, and claims substantiation matrices.
Medical Affairs Deliverables
Scientific exchange & HCP engagement
Focused on evidence-based scientific exchange, medical education, healthcare professional engagement, and the delivery of accurate, balanced medical information.
Standard Response Documents (SRDs) / Standard Medical Responses (SMRs)
Scientifically referenced, MLR-reviewed and approved response documents used by Medical Information teams to address unsolicited on-label and off-label healthcare professional inquiries.
MSL Scientific Slide Decks
Non-promotional, evidence-based educational presentations supporting peer-to-peer scientific discussions with healthcare professionals and key opinion leaders.
Advisory Board Briefing Books & Executive Reports
Scientific briefing materials prepared for advisory board participants; outputs include comprehensive reports summarizing expert insights, clinical recommendations, and unmet medical needs.
Global Medical Plans
Strategic documents aligning medical education, scientific communications, evidence generation, external engagement, and lifecycle management activities.
Medical Information & Scientific Resources
Scientific monographs, evidence dossiers, frequently asked questions (FAQs), scientific lexicons, disease-state reviews, and product training materials supporting internal and field medical teams.
Medical Education & Training Modules
Comprehensive disease-state and product education curricula developed for Medical Affairs, Medical Information, and MSL organizations.
Patient & Caregiver Communications
Disease awareness materials, patient advocacy group briefings, clinical trial recruitment content, and other scientifically grounded resources designed to engage patients, caregivers, and advocacy communities in accessible, evidence-based language.
MLR Review Preparation & Support
Structured preflight review support to optimize documents prior to Medical-Legal-Regulatory (MLR) submission, including claims substantiation matrices, reference annotation packages, and compliance checklists to reduce internal review cycles.
Digital & Omnichannel Medical Content
Scientific content for MSL e-detailing modules, interactive scientific platforms, congress digital hubs, and other digital formats — bridging rigorous medical evidence with modern engagement channels.
Clinical & Regulatory Writing
ICH-compliant regulatory documentation
Focused on the development of ICH-compliant regulatory documentation supporting clinical development, regulatory submissions, marketing authorization, and ongoing pharmacovigilance.
Clinical Study Reports (CSRs)
ICH E3-compliant comprehensive reports describing study design, methodology, statistical analyses, efficacy outcomes, and safety findings for individual clinical trials.
Clinical Trial Protocols & Protocol Amendments
Detailed documents defining study objectives, methodology, eligibility criteria, statistical analysis plans, and operational conduct for clinical investigations.
Investigator's Brochures (IBs)
Periodically updated compilations of clinical and nonclinical data supporting the safe conduct of investigational studies.
Aggregate Safety Reports
Development Safety Update Reports (DSURs), Periodic Benefit-Risk Evaluation Reports (PBRERs), and other cumulative safety assessments supporting regulatory compliance and pharmacovigilance.
Clinical Trial Safety Narratives
Patient-level narratives describing serious adverse events (SAEs), adverse events of special interest (AESIs), and deaths occurring during clinical development.
CTD Clinical Summaries
Preparation of Module 2.5 (Clinical Overview) and Module 2.7 (Clinical Summary), providing the integrated clinical narrative supporting NDAs, MAAs, and other global regulatory submissions.
Regulatory Submission Support
Briefing documents, orphan drug applications, pediatric development documents, risk management documentation (e.g., REMS, RMPs), and other regulatory writing deliverables supporting interactions with global health authorities including the FDA, EMA, PMDA, and Health Canada.
Health Economics, Outcomes Research & Payer Communications
Value evidence for market access & reimbursement
Focused on generating, synthesizing, and communicating economic and real-world evidence to support market access, reimbursement, and value-based decision-making.
HEOR Manuscripts & Posters
Peer-reviewed publications and congress presentations reporting cost-effectiveness analyses, budget impact models, quality-of-life outcomes, and comparative effectiveness findings.
Formulary & Market Access Dossiers
AMCP-format dossiers, pCODR submissions, and other payer-facing value documentation presenting clinical, economic, and humanistic evidence to support formulary listing and reimbursement decisions.
Payer Value Dossiers & Evidence Summaries
Structured summaries of clinical and economic evidence tailored for health technology assessment (HTA) bodies, managed care organizations, and integrated delivery networks.
Network Meta-Analyses (NMAs) & Indirect Treatment Comparisons (ITCs)
Statistical synthesis manuscripts and reports positioning a therapy within the competitive treatment landscape for both scientific publication and payer audiences.
Real-World Evidence (RWE) Communications
Manuscripts, congress abstracts, and payer-facing summaries reporting registry studies, claims database analyses, and other real-world data supporting label expansions, comparative effectiveness, and post-marketing commitments.
Budget Impact Models & Economic Model Documentation
Technical reports and plain-language summaries of pharmacoeconomic models, including model validation documentation and dossier-ready outputs.
Partner With Us
Advance Your Publication Strategy
Brief us on your upcoming deliverables, timelines, and therapeutic focus. We will review your project requirements and follow up with a strategic consultation within two business days.